ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Zoloft For GAD & Social Anxiety Disorder: Usage & Side Effects Guide Released

A Mission for Michael, a residential mental health center operating in Southern California, Minnesota, and Virginia, has released a guide on using Zoloft to treat anxiety disorders.

-- The latest guide from A Mission for Michael (AMFM) covers the mechanisms behind the drug, typical dosing requirements, and potential side effects. In the resource, the AMFM team also highlights specific interactions with other medications and which demographics should avoid taking Zoloft.

More information is available at https://amfmtreatment.com/zoloft-for-anxiety/

Anxiety continues to affect millions of Americans, with generalized anxiety disorder (GAD) and social anxiety disorder impacting 6.8 million and 15 million adults, respectively. In spite of the prevalence of anxiety disorders, less than half receive treatment, according to the Anxiety and Depression Association of America, and this treatment gap is caused, in part, by accessibility issues and lack of information on available treatment options.

According to A Mission for Michael’s guide, the antidepressant Zoloft is often prescribed to treat anxiety. Zoloft, the branded form of sertraline, functions as a selective serotonin reuptake inhibitor (SSRI) that increases serotonin levels in the brain, correcting neurochemical imbalances associated with these conditions and regulating moods. Zoloft is known to be effective in relieving feelings of anxiety and fear and reducing compulsions, and it is also approved by the FDA for use in treating panic disorders and PTSD.

For anxiety disorders specifically, while Zoloft is mainly used for social anxiety disorder, it can also treat GAD. However, A Mission for Michael’s guide says that the medication does not work immediately: symptom improvement generally occurs within two to six weeks, though full therapeutic effects may require six to eight weeks.

In terms of possible side effects, some individuals may experience nausea, temporary increases in anxiety, and headaches shortly after beginning their medication, while others may experience more severe side effects from Zoloft, including seizures, persistent vomiting, or suicidal thoughts.

While Zoloft is considered a lower-risk medication compared to other antidepressants, the team says long-term usage can result in sexual problems, weight gain, emotional numbness, and dependence. Individuals on the drug should avoid alcohol and any foods or beverages that contain cacao or caffeine, as combining sertraline with these substances may cause high fever, nausea, tremors, sweating, and agitation.

Finally, the resource states that Zoloft may also interact with fentanyl, antipsychotic medications, NSAIDs, and SNRIs; individuals on these drugs are encouraged to speak to their physician before taking the medication.

Interested parties can learn more by visiting https://amfmtreatment.com/

Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: A Mission for Michael (AMFM)
Address: 30310 Rancho Viejo Rd. , San Juan Capistrano, California 92675, United States
Website: https://amfmtreatment.com/

Source: PressCable

Release ID: 89180171

Should you identify any discrepancies, concerns, or inaccuracies in the content provided in this press release or require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team is committed to addressing your concerns within 8 hours by taking necessary actions to resolve identified issues diligently or guiding you through the necessary steps for removal. Our dedication lies in providing accurate and reliable information.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.28
-8.84 (-3.70%)
AAPL  248.06
-7.47 (-2.92%)
AMD  231.49
-0.34 (-0.15%)
BAC  52.05
-0.92 (-1.75%)
GOOG  323.22
-7.12 (-2.16%)
META  605.57
-14.68 (-2.37%)
MSFT  454.09
-5.77 (-1.26%)
NVDA  179.57
-6.66 (-3.57%)
ORCL  181.35
-9.74 (-5.10%)
TSLA  421.24
-16.26 (-3.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.